SEARCH

SEARCH BY CITATION

References

  • 1
    Leoncini L,Raphael M,Stein H, et al., editors. Burkitt Lymphoma. Lyon: International Agency for Research on Cancer (IARC); 2008. pp 262264.
  • 2
    Klein G. Burkitt lymphoma—A stalking horse for cancer research? Semin Cancer Biol 2009; 19: 347350.
  • 3
    Leucci E,Cocco M,Onnis A, et al. MYC translocation-negative classical Burkitt lymphoma cases: An alternative pathogenetic mechanism involving miRNA deregulation. J Pathol 2008; 216: 440450.
  • 4
    Hummel M,Bentink S,Berger H, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006; 354: 24192430.
  • 5
    Dave SS,Fu K,Wright GW, et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 2006; 354: 24312442.
  • 6
    Mbulaiteye SM,Anderson WF,Bhatia K, et al. Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005. Int J Cancer 2010; 126: 17321739.
  • 7
    Mbulaiteye SM,Biggar RJ,Bhatia K, et al. Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005. Pediatr Blood Cancer 2009; 53: 366370.
  • 8
    Ogwang MD,Bhatia K,Biggar RJ,Mbulaiteye SM. Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer 2008; 123: 26582663.
  • 9
    Guech-Ongey M,Simard EP,Anderson WF, et al. AIDS-related Burkitt lymphoma in the United States: What do age and CD4 lymphocyte patterns tell us about etiology and/or biology? Blood 2010; 116: 56005604.
  • 10
    Smith SM. AIDS-related BL and CD4 count: A clue? Blood 2010; 116: 54355436.
  • 11
    Macmahon B. Epidemiological evidence of the nature of Hodgkin's disease. Cancer 1957; 10: 10451054.
  • 12
    Jarrett RF. Viruses and Hodgkin's lymphoma. Ann Oncol 2002; 13: 2329.
  • 13
    Klapper W,Szczepanowski M,Burkhardt B, et al. Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood 2008; 112: 13741381.
  • 14
    Ferlay J,Parkin DM,Curado MP, et al. Cancer Incidence in Five Continents, Volumes I to IX: IARC CancerBase No. 9. Lyon, France: International Agency for Research on Cancer; 2010.
  • 15
    Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. Geneva: World Health Organization; 1977.
  • 16
    International Statistical Classification of Diseases and Related Health Problem, Tenth Revision. Geneva: World Health Organization; 1992.
  • 17
    Manual of Tumor Nomenclature. New York: American Cancer Society; 1951.
  • 18
    International Classification of Diseases for Oncology. Geneva: World Health Organization; 1976.
  • 19
    International Classification of Diseases for Oncology. Geneva: World Health Organization; 1990.
  • 20
    Fritz A,Percy C,Jack A,Shanmugaratnam K,Sobin LH,Parkin DM,Whelan S, editors. International Classification of Diseases for Oncology (ICD-O-3). Geneva (Switzerland): World Health Organization; 2000.
  • 21
    Doll R,Payne P,Waterhouse JAH, editors. Cancer Incidence in Five Continents. Geneva: Union Internationale Contre le Cancer; 1966.
  • 22
    Devesa SS,Donaldson J,Fears T. Graphical presentation of trends in rates. Am J Epidemiol 1995; 141: 300304.
  • 23
    Kim HJ,Fay MP,Feuer EJ,Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335351.
  • 24
    Holford TR. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health 1991; 12: 425457.
  • 25
    Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics 1983; 39: 311324.
  • 26
    Rosenberg PS,Anderson WF. Proportional hazards models and age-period-cohort analysis of cancer rates. Stat Med 2010; 29: 12281238.
  • 27
    Tarone RE,Chu KC. Evaluation of birth cohort patterns in population disease rates. Am J Epidemiol 1996; 143: 8591.
  • 28
    AIDS Epidemic Update: November 2009. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO); 2009.
  • 29
    Ries LAG,Devesa SS. Cancer incidence, mortality, and patient survival in the United States. In: Schottenfeld D,Fraumeni JF,Jr, editors. Cancer Epidemiology and Prevention. New York: Oxford University Press; 2006. pp 139167.
  • 30
    Perkins AS,Friedberg JW. Burkitt lymphoma in adults. Hematology Am Soc Hematol Educ Program 2008; 2008: 341348.
  • 31
    Thomas DA,Faderl S,O'Brien S, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer 2006; 106: 15691580.
  • 32
    Kelly JL,Toothaker SR,Ciminello L, et al. Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens. Clin Lymphoma Myeloma 2009; 9: 307310.
  • 33
    Mbulaiteye SM,Parkin DM,Rabkin CS. Epidemiology of AIDS-related malignancies an international perspective. Hematol Oncol Clin North Am 2003; 17: 673696,v.
  • 34
    Parkin DM. The evolution of the population-based cancer registry. Nat Rev Cancer 2006; 6: 603612.
  • 35
    Naresh KN,Ibrahim HA,Lazzi S, et al. Diagnosis of Burkitt lymphoma using an algorithmic approach—applicable in both resource-poor and resource-rich countries. Br J Haematol, 2011; doi:10.1111/j.1365-2141.2011.08771.x (Epub ahead of print).
  • 36
    Wright DH. What is Burkitt's lymphoma and when is it endemic? Blood 1999; 93: 758.
  • 37
    Haralambieva E,Boerma EJ,van Imhoff GW, et al. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surg Pathol 2005; 29: 10861094.
  • 38
    Harris NL,Jaffe ES,Diebold J, et al. Lymphoma classification—From controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol 2000; 11: 310.